Relay Therapeutics logo

Director, Clinical Operations

Relay Therapeutics

Cambridge, MAOnsitePosted 1 day ago
Full TimeDirector & AboveClinical DevelopmentBiotechnology
Original posting ↗

Summary

As Director, Clinical Operations – Global Study Lead, you will be accountable for the end-to-end planning and execution of one or more global studies within Relay Tx's breast cancer (BC) program. You will lead cross-functional study teams and CRO partners to deliver registrational-quality studies with speed, rigor and data integrity. You will be an integrated member of the BC clinical development team, bringing operational insight to study design and program strategy, and translating Relay's innovative science into impactful medicines for patients with breast cancer. You will report to the Vice President, Clinical Operations.

Job description

The Opportunity

As Director, Clinical Operations – Global Study Lead, you will be accountable for the end-to-end planning and execution of one or more global studies within Relay Tx's breast cancer (BC) program. You will lead cross-functional study teams and CRO partners to deliver registrational-quality studies with speed, rigor and data integrity. You will be an integrated member of the BC clinical development team, bringing operational insight to study design and program strategy, and translating Relay's innovative science into impactful medicines for patients with breast cancer. You will report to the Vice President, Clinical Operations.

Your Role

  • Serve as the Global Study Lead, accountable for the delivery of assigned BC studies from protocol concept through study start-up, enrollment, database lock and clinical study report, on time, on budget and to quality.
  • Lead the cross-functional study team (Clinical Science, Medical, Biostatistics, Data Management, Clinical Supply, Regulatory, Safety, Quality and Translational), setting clear priorities, driving decisions and escalating risks appropriately.
  • Bring operational and feasibility input to protocol design, country and site selection, and enrollment strategy, ensuring study plans are aligned with the BC clinical development strategy and corporate goals.
  • Own the study's integrated timelines, budget, forecasts, risk and mitigation plans, and key performance metrics, and provide clear, data-driven status updates to program and senior leadership.
  • Select, contract and oversee CROs and specialty vendors (e.g., central lab, imaging, IRT, eCOA), holding partners accountable for performance and quality through governance and active issue management.
  • Drive enrollment and site performance across a global footprint (North America, Europe and other regions), using data and creative recruitment and retention approaches to accelerate timelines.
  • Build and maintain strong relationships with investigators, key opinion leaders, site staff and cooperative groups in the breast oncology community, and be able to explain complex scientific and operational topics to these stakeholders.
  • Ensure inspection readiness and compliance with GCP, ICH, and applicable global regulations, including oversight of the Trial Master File, monitoring strategy, protocol deviations and corrective/preventive actions.
  • Contribute the Clinical Operations sections of key regulatory and study documents (e.g., protocols and amendments, IND/CTA submissions, briefing packages, NDA/MAA components, annual reports, study postings and clinical study reports).
  • Partner with Clinical Operational Excellence to apply and improve study systems, processes and SOPs, and share lessons learned across the BC program and the broader Clinical Operations team.
  • Lead, coach and develop clinical study managers, clinical trial associates and other study team members, and serve as a leadership role model within Clinical Development Operations.

Your Background

  • 10+ years of experience in the biopharma or CRO industry, including significant experience leading global studies as a study lead or equivalent.
  • Led global Phase 2 and/or Phase 3 oncology studies end to end; experience with registrational studies is strongly preferred.
  • Breast cancer or solid tumor oncology experience; familiarity with endocrine therapy, targeted therapy combinations, or the metastatic breast cancer treatment landscape is a plus.
  • Track record of hands-on CRO and vendor oversight in an outsourced model, including contracting, budget management and performance governance.
  • Strong, current knowledge of global regulatory and compliance requirements, including US CFR, EU CTR, and ICH GCP, and have supported inspections or audits.
  • Proven ability to deliver to aggressive timelines, using data, technology and creative problem-solving to accelerate enrollment and maintain data integrity.
  • Lead through influence, building alignment across functions and with external partners, and communicate clearly and confidently with senior leaders, investigators and vendors.
  • Motivated self-starter who flourishes in a fast-paced, growing biotech environment and can manage multiple priorities with a high degree of attention to detail.
  • Line management or team leadership experience and enjoy mentoring and developing talent.
  • Bachelor's degree in a scientific or health-related field required; advanced degree preferred.

Requirements

  • 10+ years of experience in the biopharma or CRO industry
  • Significant experience leading global studies as a study lead or equivalent
  • Led global Phase 2 and/or Phase 3 oncology studies end to end
  • Breast cancer or solid tumor oncology experience
  • Hands-on CRO and vendor oversight in an outsourced model, including contracting, budget management and performance governance
  • Strong knowledge of global regulatory and compliance requirements, including US CFR, EU CTR, and ICH GCP
  • Supported inspections or audits
  • Proven ability to deliver to aggressive timelines
  • Lead through influence and build alignment across functions and external partners
  • Line management or team leadership experience
  • Bachelor's degree in a scientific or health-related field required

Company overview

Relay Therapeutics is a clinical-stage precision medicines company that is transforming the drug discovery process through the integration of computational and experimental technologies. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company leverages unparalleled insights into protein motion and how this dynamic behavior relates to protein function. Their innovative approach combines unprecedented computational power with leading-edge experimental techniques across structural biology, biophysics, chemistry, and biology. The company's proprietary Dynamo platform enables the visualization and analysis of protein mobility in 3D, allowing researchers to study ligand-binding pockets and detect protein-ligand interactions. Relay Therapeutics focuses initially on developing therapeutics in oncology, with programs targeting precision oncology and genetic diseases. As a publicly traded company (NASDAQ: RLAY), they have raised over $520 million in funding and employ approximately 51-200 professionals dedicated to advancing novel therapies for patients with unmet medical needs.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.